The American Association of Clinical Endocrinology (AACE) guidelines support GLP-1 use as preferred second-line therapy, and this documentation strengthens exception requests
Unlike Ozempic, which is FDA-approved for type 2 diabetes, Wegovy is FDA-approved specifically for chronic weight management when combined with a reduced-calorie diet and increased physical activity
Old approach: Focus on blood sugar control alone New approach: Target multiple metabolic pathways simultaneously Blood sugar regulation Weight management Liver health Cardiovascular protection Inflammation reduction We're moving toward truly holistic metabolic management, not just "diabetes management." And this is probably not the end
In the Yale study, researchers tested once-weekly injections of 1 mg, 4 mg, 8 mg, and 12 mg for 48 weeks
With that said, some are better than others due to their ingredients, transparency and simplicity